Harvard Bioscience (HBIO) Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.

Which has more volatility & risk, HBIO or TMO?

Harvard Bioscience has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Is HBIO or TMO more profitable?

Thermo Fisher Scientific has a net margin of 14.78% compared to Harvard Bioscience's net margin of -14.57%. Thermo Fisher Scientific's return on equity of 17.51% beat Harvard Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-14.57%	-4.64%	-2.40%
Thermo Fisher Scientific	14.78%	17.51%	8.52%

Do analysts recommend HBIO or TMO?

Harvard Bioscience currently has a consensus target price of $4.50, suggesting a potential upside of 660.01%. Thermo Fisher Scientific has a consensus target price of $653.23, suggesting a potential upside of 27.14%. Given Harvard Bioscience's stronger consensus rating and higher probable upside, research analysts plainly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	2.82

Which has preferable valuation and earnings, HBIO or TMO?

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$94.14M	0.28	-$3.41M	-$0.29	-2.04
Thermo Fisher Scientific	$42.88B	4.52	$6.34B	$16.53	31.08

Do insiders & institutionals believe in HBIO or TMO?

80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.0% of Harvard Bioscience shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the media favor HBIO or TMO?

In the previous week, Thermo Fisher Scientific had 59 more articles in the media than Harvard Bioscience. MarketBeat recorded 61 mentions for Thermo Fisher Scientific and 2 mentions for Harvard Bioscience. Thermo Fisher Scientific's average media sentiment score of 1.31 beat Harvard Bioscience's score of -1.00 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Overall Sentiment
Harvard Bioscience	Negative
Thermo Fisher Scientific	Positive

Does the MarketBeat Community believe in HBIO or TMO?

Thermo Fisher Scientific received 714 more outperform votes than Harvard Bioscience when rated by MarketBeat users. Likewise, 80.82% of users gave Thermo Fisher Scientific an outperform vote while only 72.07% of users gave Harvard Bioscience an outperform vote.

Company	Underperform	Outperform
Harvard Bioscience	Outperform Votes 369 72.07%	Underperform Votes 143 27.93%
Thermo Fisher Scientific	Outperform Votes 1083 80.82%	Underperform Votes 257 19.18%

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 14 of the 18 factors compared between the two stocks.